PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
16-Feb-2024 Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin A Nephropathy Businesswire
16-Feb-2024 Thermo Fisher Scientific Recognized by Customers for Contract Manufacturing Leadership Businesswire
16-Feb-2024 Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer Businesswire
16-Feb-2024 Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires Businesswire
16-Feb-2024 KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting Businesswire
16-Feb-2024 Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 Businesswire
16-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
16-Feb-2024 GE HealthCare Technologies Inc. Prices Secondary Offering of 13,000,000 Shares Businesswire
16-Feb-2024 Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range Businesswire
16-Feb-2024 CORRECTING and REPLACING Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS) Businesswire
16-Feb-2024 Protesters Blast NACHC’s Self-Serving Deal with PhRMA, says AHF Businesswire
16-Feb-2024 GE HealthCare Technologies Inc. Commences Secondary Offering of 13,000,000 Shares Businesswire
16-Feb-2024 Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results Businesswire
16-Feb-2024 AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million Businesswire
16-Feb-2024 Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights Businesswire
16-Feb-2024 Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products Businesswire
15-Feb-2024 Preclinical Data on PIV5-based Intranasal Vaccine Against Lyme Disease Demonstrates Durable Immune Response Businesswire
15-Feb-2024 Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Lymphoma (AML) and High-Risk Myelodysplastic Syndromes (MDS) Businesswire
15-Feb-2024 Meatable Strengthens Board of Directors to Accelerate Growth of Breakthrough Food Technology Businesswire
15-Feb-2024 Pyros Pharmaceuticals Announces Positive Outcome of the European Decentralised Procedure for Approval of VIGZIP™ (vigabatrin oral solution) Businesswire